Editas Medicine's share price bounce is expected after a sig...
Editas Medicine's share price bounce is expected after a significant drop, but the underlying business needs to justify a higher price. The weak revenue result is concerning, and the falling share price is likened to 'trying to catch a falling knife'. The recent share price recovery is viewed skeptically.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000030508c5dccc324.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment